Royce & Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.96M Buy
406,175
+53,878
+15% +$1.32M 0.08% 388
2025
Q4
$9.43M Sell
352,297
-14,025
-4% -$361K 0.1% 327
2025
Q3
$9.76M Buy
366,322
+83,135
+29% +$2.15M 0.1% 307
2025
Q2
$6.5M Buy
283,187
+35,329
+14% +$877K 0.07% 409
2025
Q1
$7.19M Buy
247,858
+238,956
+2,684% +$7.63M 0.08% 375
2024
Q4
$331K Sell
8,902
-174
-2% -$7.96K ﹤0.01% 784
2024
Q3
$440K Hold
9,076
﹤0.01% 807
2024
Q2
$363K Buy
+9,076
New +$376K ﹤0.01% 813
2023
Q2
Sell
-22,315
Closed -$837K 915
2023
Q1
$837K Buy
+22,315
New +$732K 0.01% 787
2022
Q3
Sell
-13,546
Closed -$471K 933
2022
Q2
$471K Sell
13,546
-7,354
-35% -$262K ﹤0.01% 840
2022
Q1
$750K Buy
20,900
+894
+4% +$25.4K 0.01% 836
2021
Q4
$466K Buy
+20,006
New +$409K ﹤0.01% 899

Other funds holding AMPH